Disposable Medical Device Market

The report "Disposable Medical Device Market by Device (Drug Delivery Devices, Surgical & Procedural Instruments, Personal Protective Equipment, Catheters & Tubes), Device Class (I, II, III), Material (Plastic-based, Metal-based, Rubber-based), and Application - Global Forecast to 2030" The global disposable medical device market is projected to reach 144.85 billion in 2030, growing from USD 113.95 billion in 2025, at a CAGR of 4.9% between 2025 and 2030. The increasing global demand for infection control and rising surgical volumes drive the growth of the disposable medical device market. Surge in chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, requires continuous medical care, boosting the use of single-use devices for diagnostics, treatment, and monitoring. The aging global population also contributes to high hospitalization and surgical rates, fueling demand. Technological advancements in materials and design have made disposable devices more efficient, affordable, and user-friendly. The COVID-19 pandemic also reinforced the need for sterile, ready-to-use medical products, accelerating their adoption across hospitals, ambulatory surgical centers, and home care settings. Moreover, increasing healthcare investments in emerging markets and government policies promoting infection prevention and healthcare access are expanding the global footprint of disposable medical devices.

Browse 611 market data Tables and 63 Figures spread through 595 Pages and in-depth TOC on "Disposable Medical Device Market by Device (Drug Delivery Devices, Surgical & Procedural Instruments, Personal Protective Equipment, Catheters & Tubes), Device Class (I, II, III), Material (Plastic-based, Metal-based, Rubber-based), and Application – Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/disposable-medical-device-market-154383032.html

By device type, the drug delivery devices segment is projected to grow at the highest CAGR during the forecast period.

The adoption of drug delivery devices is driven by the increasing prevalence of chronic diseases, such as diabetes, asthma, and cardiovascular conditions, which require regular and precise medication administration. Devices like disposable syringes, insulin pens, auto-injectors, inhalers, and transdermal patches offer convenience, safety, and ease of use, which makes them ideal for clinical and home-based care. Additionally, the rising demand for self-administration and minimally invasive treatments is also propelling the use of these devices, particularly among aging populations and patients in remote areas. Moreover, the risk of contamination and the need for strict hygiene protocols encourage the shift from reusable to single-use drug delivery systems. Technological advancements that enhance dosage accuracy, patient compliance, and user experience further support market growth, along with expanding vaccination programs and the increasing role of biologics and specialty drugs that require dedicated delivery mechanisms.

By application, the general surgery segment is projected to account for the largest share during the forecast period.

The general surgery segment is experiencing significant growth in the disposable medical devices market due to the rising number of surgical procedures globally, driven by an aging population, increasing incidence of chronic and lifestyle-related diseases, and greater access to surgical care. Hospitals and surgical centers are increasingly adopting disposable instruments, such as scalpels, forceps, staplers, and drapes, to reduce the risk of cross-contamination and improve patient safety. The shift toward minimally invasive and outpatient surgeries has also increased the demand for sterile, cost-effective, ready-to-use surgical kits and instruments. Additionally, growing healthcare infrastructure in emerging economies and advancements in disposable device technology further support expanding general surgery applications. The need for enhanced operating room efficiency and reduced sterilization burden is making disposable solutions an attractive choice, thereby driving consistent growth in this segment.

Europe accounted for the second-largest share of the disposable medical device market in 2024.

The growth of the disposable medical device market in Europe is driven by stringent infection control regulations, rising healthcare expenditure, and an aging population requiring frequent medical interventions. European countries have strong regulatory frameworks prioritizing patient safety and hygiene, encouraging the widespread adoption of single-use devices to prevent healthcare-associated infections (HAIs). The increasing burden of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, is further boosting the demand for disposable diagnostic, surgical, and monitoring tools. Additionally, the region’s focus on sustainability is prompting innovations in eco-friendly disposable materials, aligning product development with environmental goals. Growth is also supported by the expansion of outpatient and home-based care services, which rely heavily on convenient, sterile, and easy-to-use medical products. These factors drive the steady rise of the European disposable medical devices market.

Key players in the disposable medical device market include Johnson & Johnson (US), Baxter. (US), BD (US), Cardinal Health, Inc. (US), Abbott (US), Medtronic (Ireland), Solventum (US), Boston Scientific Corporation (US), Stryker Corporation (US), Teleflex Incorporated (US), B Braun SE. (US), Terumo Corporation (Japan), Nipro Corporation (Japan), Merit Medical Systems. (US), Alcon Inc. (Switzerland), Medline Industries, Inc. (US), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (US), STERIS. (US), Integra LifeSciences Holdings Corporation (US), Coloplast (Denmark), Kirwan Surgical Products, LLC (US), Owens & Minor, Inc. (US), Aspen Surgical Products, Inc. (US), and Paul Hartmann AG (Germany).

Don’t miss out on business opportunities in Disposable Medical Device Market. Speak to our analyst and gain crucial industry insighs that will help your businessgrow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/